Accepted for/Published in: JMIR Human Factors
Date Submitted: May 13, 2026
Date Accepted: Oct 2, 2026
Patient Perspectives on a Symptom Assessment Application in Emergency Care – Results from a Qualitative Study within the AKUSYM Trial
ABSTRACT
Background:
Symptom Assessment Applications (SAAs) allow laypersons to input their medical history and symptoms, generating a report with probable diagnoses and recommended next steps for medical care. Numerous and varied research findings exist regarding their diagnostic and triage accuracy, usability, acceptance, and user characteristics, including their use in various settings. However, the perspective of low-acuity emergency patients on the benefits and challenges of using SAAs has not yet been explored.
Objective:
This study aimed to explore patients’ experiences and attitudes toward SAA use before consultation in the emergency department (ED) and to identify perceived benefits and challenges of integrating SAAs into emergency care from the patients’ perspective.
Methods:
We conducted semi-structured interviews with self-referred, walk-in patients at two EDs and an ED-associated outpatient on-call practice in Berlin that were allocated to the intervention group of the AkuSym trial. Participants had self-assessed their health complaints using the Ada Health SAA before their first encounter with the treating physician. Interviews were audio-recorded, transcribed, and analyzed using qualitative content analysis with deductively and inductively developed categories.
Results:
Eighteen patients were interviewed between July and November 2022. Most participants stated that they would use an SAA again, including outside the emergency care setting. Key factors influencing reuse were precise symptom queries and clear, layperson-friendly medical content. Patients' trust in medical professionals was higher than in SAA assessments, and personal doctor–patient contact remained essential. The SAA was perceived primarily as a source of preliminary information and a supplement to doctor–patient contact. It helped participants reflect on and articulate their symptoms. Participants also saw potential for SAAs to support decisions about whether and where to seek medical care, to provide self-help recommendations for minor complaints, and to enable more informed participation in diagnostic discussions. Concerns included inaccurate or incomplete symptom input, difficulties understanding and interpreting SAA assessments, and receiving alarming or unclear information that could increase anxiety or complicate the subsequent consultation. Identified challenges included enabling information transfer through digital interfaces and ensuring data protection. Participants suggested solutions such as voluntary access via waiting-room QR codes, linking assessments to electronic patient records, and guiding patients to appropriate healthcare services.
Conclusions:
Meaningful integration of SAA use into emergency care requires a clear understanding of how these assessments should be used during the doctor–patient consultation, as well as ensuring accessibility for patients with limited digital health literacy. Such tools have the potential to improve health literacy and empower patients, potentially leading to more efficient healthcare use. Linking SAA assessments to a public website that provides evidence-based, layperson-friendly information and contact details for appropriate healthcare providers could help patients understand their results and identify suitable care options. Clinical Trial: German Clinical Trials Register (DRKS): DRKS00028598. Registered on 25.03.2022
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.